Clinical trial Recruiting at 1 site Interventional Ages 4 to 18

Using rTMS to treat spasticity in children with cerebral palsy

Official title: Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Spasticity in Children With Hemiplegic Cerebral Palsy/ Hemiplegia Due to Acquired Brain Injury - a Randomized Controlled Trial

Run by The University of Hong Kong · NCT06128746 · Data updated 2026-11-12

This study is testing if a new treatment called rTMS can help reduce muscle stiffness and improve movement in children with hemiplegic cerebral palsy.

Quick facts

Study typeInterventional
Ages4 Years to 18 Years
SexAll
Enrollment20 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedJanuary 13, 2024
Main results expectedDecember 2029
Study endsDecember 2029
Registry record updatedSeptember 28, 2026
Trial IDNCT06128746 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 7 to 18 years diagnosed with hemiplegic cerebral palsy and exhibiting upper limb spasticity.

Probably not a fit

Patients with severe spasticity, uncontrollable epilepsy, or recent interventions like botulinum toxin injections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of repetitive transcranial magnetic stimulation (rTMS) on children with hemiplegic cerebral palsy. Participants will receive 10 days of rTMS treatment followed by intensive training of the impaired limb, with assessments of spasticity and neurophysiological changes through MRI scans. The study aims to compare the outcomes of the rTMS group with a sham group to determine the efficacy of this non-invasive treatment in improving motor function. The goal is to provide a new therapeutic option for managing spasticity in this population.

Why it matters

Potential benefit: If successful, this treatment could significantly improve motor function and quality of life for children with cerebral palsy by reducing spasticity.

How similar studies have gone: Previous studies have shown that rTMS can improve hand function in hemiparetic patients, but limited research exists specifically on its effects on spasticity in children with cerebral palsy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged between 4 years and 18 years
* Diagnosis of hemiplegia
* Upper limb spasticity ≥ 1
* IQ ≥ 50

Exclusion Criteria:

* Any contra-indications to rTMS
* Severe spasticity (score of 4 or more in Ashworth scale)
* Uncontrollable epilepsy
* History of Botulinum toxin A injection in previous 6 months
* Upper limb casting in previous 6 months

Where it's running

  • Li Ka Shing Faculty of Medicine
    Hong Kong, Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.